Boron Therapeutics on the Horizon
- 1 September 2001
- journal article
- review article
- Published by Wolters Kluwer Health in American Journal of Therapeutics
- Vol. 8 (5) , 321-328
Abstract
No pharmaceutical based on boron has yet made it to market, but this may soon change. The new millennium has brought with it some unique classes of bioactive boron compounds that are sufficiently mature in development to be considered significant and timely advances in their respective chemotherapeutic areas. Because boron is seldom seen as a constituent of a bioactive agent, this review relates some of the pertinent biologic and physiologic properties of boron and then describes in detail those boron-based agents clearly visible on the therapeutic horizon. Highlighted agents include boronic acids and boron heterocycles as potent proteasome inhibitors, β-lactamase inhibitors, dipeptidyl peptidase inhibitors, inositol trisphosphate receptor modulators, antibacterials, and antiestrogens. As these new agents are welcomed into the therapeutic armamentarium, others will surely follow and the prescribing clinician will already have an awareness and appreciation of the unique benefits that these compounds have to offer.Keywords
This publication has 95 references indexed in Scilit:
- Permeability and Channel-Mediated Transport of Boric Acid across Membrane Vesicles Isolated from Squash RootsPlant Physiology, 2000
- Boron Stimulates Yeast (Saccharomyces cerevisiae) GrowthThe Journal of Nutrition, 1999
- Total Synthesis of Tartrolon BJournal of the American Chemical Society, 1999
- Boromycin, an Anti-HIV AntibioticBioscience, Biotechnology, and Biochemistry, 1996
- Antibiotics from gliding bacteria. No.60. The Tartrolons, New Boron-containing Antibiotics from a Myxobacterium, Sorangium cellulosum.The Journal of Antibiotics, 1995
- Antibiotics from gliding bacteria, LVII. Tartrolons: New boron‐containing macrodiolides from Sorangium cellulosumEuropean Journal of Organic Chemistry, 1994
- Biosynthesis of the boron-containing antibiotic aplasmomycin. Nuclear magnetic resonance analysis of aplasmomycin and desboroaplasmomycin.The Journal of Antibiotics, 1980
- Structure of aplasmomycin.The Journal of Antibiotics, 1977
- Studies on marine microorganisms. V. A new antibiotic, aplasmomycin, produced by a streptomycete isolated from shallow sea mud.The Journal of Antibiotics, 1976
- Stoffwechselprodukte von Mikroorganismen. 57. Mitteilung. BoromycinHelvetica Chimica Acta, 1967